These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33875038)

  • 1. Vitamins and Infusion of Levodopa-Carbidopa Intestinal Gel.
    Taher J; Naranian T; Poon YY; Merola A; Mestre T; Suchowersky O; Kulasingam V; Fasano A
    Can J Neurol Sci; 2022 Jan; 49(1):19-28. PubMed ID: 33875038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraduodenal levodopa-carbidopa intestinal gel infusion improves both motor performance and quality of life in advanced Parkinson's disease.
    Chang FC; Kwan V; van der Poorten D; Mahant N; Wolfe N; Ha AD; Griffith JM; Tsui D; Kim SD; Fung VS
    J Clin Neurosci; 2016 Mar; 25():41-5. PubMed ID: 26777085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal delivery.
    Müller T; van Laar T; Cornblath DR; Odin P; Klostermann F; Grandas FJ; Ebersbach G; Urban PP; Valldeoriola F; Antonini A
    Parkinsonism Relat Disord; 2013 May; 19(5):501-7 ; discussion 501. PubMed ID: 23453891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyneuropathy monitoring in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel.
    Pauls KAM; Toppila J; Koivu M; Eerola-Rautio J; Udd M; Pekkonen E
    Brain Behav; 2021 Dec; 11(12):e2408. PubMed ID: 34758207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral neuropathy in 30 duodopa patients with vitamins B supplementation.
    Rispoli V; Simioni V; Capone JG; Golfrè Andreasi N; Preda F; Sette E; Tugnoli V; Sensi M
    Acta Neurol Scand; 2017 Dec; 136(6):660-667. PubMed ID: 28608472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review.
    Antonini A; Odin P; Pahwa R; Aldred J; Alobaidi A; Jalundhwala YJ; Kukreja P; Bergmann L; Inguva S; Bao Y; Chaudhuri KR
    Adv Ther; 2021 Jun; 38(6):2854-2890. PubMed ID: 34018146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of levodopa/carbidopa intestinal gel versus oral levodopa/carbidopa on B vitamin levels and neuropathy.
    Loens S; Chorbadzhieva E; Kleimann A; Dressler D; Schrader C
    Brain Behav; 2017 May; 7(5):e00698. PubMed ID: 28523235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Practices for Outpatient Initiation of Levodopa-Carbidopa Intestinal Gel for Management of Advanced Parkinson's Disease in the United States.
    Amjad F; Bhatti D; Davis TL; Oguh O; Pahwa R; Kukreja P; Zamudio J; Metman LV
    Adv Ther; 2019 Sep; 36(9):2233-2246. PubMed ID: 31278691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of levodopa-carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson's disease: a multicenter Romanian experience.
    Băjenaru O; Ene A; Popescu BO; Szász JA; Sabău M; Mureşan DF; Perju-Dumbrava L; Popescu CD; Constantinescu A; Buraga I; Simu M
    J Neural Transm (Vienna); 2016 Apr; 123(4):407-14. PubMed ID: 26699635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposition of zinc supplementation during levodopa-carbidopa intestinal gel treatment.
    Matsuyama H; Matsuura K; Ishikawa H; Hirata Y; Kato N; Niwa A; Narita Y; Tomimoto H
    Brain Behav; 2018 Dec; 8(12):e01143. PubMed ID: 30358126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Problems related to levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.
    Udd M; Lyytinen J; Eerola-Rautio J; Kenttämies A; Lindström O; Kylänpää L; Pekkonen E
    Brain Behav; 2017 Jul; 7(7):e00737. PubMed ID: 28729942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 24-Hour Levodopa-Carbidopa Intestinal Gel: Clinical Experience and Practical Recommendations.
    Thakkar S; Fung VSC; Merola A; Rollins M; Soileau MJ; Kovács N
    CNS Drugs; 2021 Feb; 35(2):137-149. PubMed ID: 33582982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review.
    Wirdefeldt K; Odin P; Nyholm D
    CNS Drugs; 2016 May; 30(5):381-404. PubMed ID: 27138916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jejunal Infusion of levodopa-carbidopa intestinal gel versus oral administration of levodopa-carbidopa tablets in japanese subjects with advanced Parkinson's disease: pharmacokinetics and pilot efficacy and safety.
    Othman AA; Chatamra K; Mohamed ME; Dutta S; Benesh J; Yanagawa M; Nagai M
    Clin Pharmacokinet; 2015 Sep; 54(9):975-84. PubMed ID: 25875940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diphasic dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion in Parkinson's disease.
    Meloni M; Solla P; Mascia MM; Marrosu F; Cannas A
    Parkinsonism Relat Disord; 2017 Apr; 37():92-96. PubMed ID: 28063683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa-Carbidopa Intestinal Gel Monotherapy: GLORIA Registry Demographics, Efficacy, and Safety.
    Poewe W; Bergmann L; Kukreja P; Robieson WZ; Antonini A
    J Parkinsons Dis; 2019; 9(3):531-541. PubMed ID: 31282424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyneuropathy associated with duodenal infusion of levodopa in Parkinson's disease: features, pathogenesis and management.
    Uncini A; Eleopra R; Onofrj M
    J Neurol Neurosurg Psychiatry; 2015 May; 86(5):490-5. PubMed ID: 25168395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets.
    Othman AA; Dutta S
    Br J Clin Pharmacol; 2014 Jul; 78(1):94-105. PubMed ID: 24433449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: a long-term prospective assessment.
    Merola A; Romagnolo A; Zibetti M; Bernardini A; Cocito D; Lopiano L
    Eur J Neurol; 2016 Mar; 23(3):501-9. PubMed ID: 26498913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory epileptic seizures due to vitamin B6 deficiency in a patient with Parkinson's disease under duodopa® therapy.
    Skodda S; Müller T
    J Neural Transm (Vienna); 2013 Feb; 120(2):315-8. PubMed ID: 22798026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.